Silencing of the endothelial-specific histone methyltransferase SET domain containing 1 (SET1) could inhibit cardiac fibrosis and hypertrophy by repressing endothelin-1 transcription in response to chronic AngII treatment29. This evidence concerns the gene SETD1A and fibrosis.